This is a non-core endpoint: only basic statistics are computed.
Benign neoplasm: Bones of skull and face
CD2_BENIGN_BONE_SKULL_FACE_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: Bones of skull and face
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm: Bones of skull and face
- Benign neoplasm of bone and articular cartilage
- Benign neoplasm of bone and articular cartilage
- Benign neoplasms
- Benign neoplasms
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 351 | 263 | 88 |
| Unadjusted period prevalence (%) | 0.08 | 0.09 | 0.04 |
| Median age at first event (years) | 49.97 | 49.02 | 52.80 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 310
- Matched controls
- 3099
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D16.49
ICD-10 Finland
Bones of skull and face
+∞
291.8
232
*
AAP10
NOMESCO Finland
Extirpation of a skull lesion
+∞
63.8
59
*
2130A
ICD-9 Finland
Benign neoplasm of bone and articular cartilage, Bones of skull and face
+∞
38.3
36
*
D16.40
ICD-10 Finland
Orbital bone
+∞
37.2
35
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
17.9
17
*
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
12.7
16.4
29
25
130
Kela drug reimbursment
Malignant tumour
+∞
15.8
15
*
D16.41
ICD-10 Finland
Benign tumor of the maxillary bone originating in teeth
+∞
14.7
14
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
13.6
13
*
115
Kela drug reimbursment
Breast cancer
+∞
13.6
13
*
AA1AD
NOMESCO Finland
CT of head and brain
2.9
12.8
91
389
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
+∞
12.6
12
*
D16.90
ICD-10 Finland
Bone and articular cartilage, unspecified
+∞
12.6
12
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
11.5
11
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
124.4
11.5
12
*
H02AB02
ATC
dexamethasone; systemic
14.6
11.1
18
13
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
103.1
9.5
10
*
A04AA02
ATC
granisetron; systemic, transdermal
103.1
9.5
10
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
9.4
9
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
3.9
9.2
38
108
HAB40
NOMESCO Finland
Wedge excision of mammary gland
37.9
9.1
11
*
QAE99
NOMESCO Finland
Other excision or repair surgery of skin and subcutaneous tissue in head and neck
14.6
8.8
14
10
D48.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage
12.1
8.7
15
13
D16.4
ICD-10 Finland
Benign neoplasm: Bones of skull and face
+∞
8.4
8
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
8.4
8
*
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
15.0
8.3
13
9
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
15.5
7.8
12
8
WX408
NOMESCO Finland
General anesthesy, balanced
2.2
7.4
84
446
L03AA13
ATC
pegfilgrastim; parenteral
+∞
7.3
7
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
+∞
7.3
7
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
7.3
7
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
7.3
7
*
HAC20
NOMESCO Finland
Total mastectomy
+∞
7.3
7
*
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
4.2
6.7
24
61
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
4.5
6.6
22
52
WF002
NOMESCO Finland
Radical radiotherapy
71.3
6.4
7
*
EEA10
NOMESCO Finland
Biopsy of maxilla
71.3
6.4
7
*
EEB00
NOMESCO Finland
Partial excision of maxilla
+∞
6.3
6
*
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
+∞
6.3
6
*
D05.1
ICD-10 Finland
Intraductal carcinoma in situ
+∞
6.3
6
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
6.3
6
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
6.3
6
*
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
5.6
6.2
17
32
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
148
1026
1.77
6.16
4.3
3.6
35.5
36.5
g/l
1.30
136
955
195
1510
1.66
5.07
4.3
4.1
6.5
6.6
mmol/l
0.48
184
1393
119
821
1.68
4.79
2.4
2.0
2.4
2.4
mmol/l
0.39
109
698
88
559
1.77
4.77
1.9
1.9
—
—
—
0
0
179
1382
1.60
4.52
3.5
3.3
0.0
0.0
estimate
0.00
27
250
156
1171
1.60
4.40
3.9
3.5
—
—
—
0
0
147
1097
1.59
4.20
3.7
3.2
—
—
—
0
0
121
865
1.61
4.13
2.5
2.7
—
—
—
0
0
252
2140
1.63
4.06
4.1
4.1
12.0
10.8
mm/h
0.62
238
1971
178
1402
1.55
3.94
3.5
3.3
0.0
0.0
estimate
0.00
27
244
176
1386
1.54
3.88
4.8
4.5
0.0
0.0
estimate
0.50
29
249
27
123
2.29
3.71
3.2
1.5
191.7
2.6
ug/l
0.69
19
94
243
2071
1.56
3.62
6.6
5.1
81.7
75.1
u/l
0.71
230
1916
102
728
1.57
3.41
3.8
3.4
0.0
0.0
estimate
0.50
26
249
140
1091
1.47
3.04
5.2
5.0
1.2
1.2
mmol/l
1.28
128
976
154
1226
1.46
2.98
5.5
5.3
1.2
1.2
mmol/l
1.79
130
1052
185
1529
1.44
2.91
7.1
6.6
4.4
4.1
e9/l
0.68
160
1326
92
664
1.52
2.88
2.4
2.5
0.5
0.4
e6/l
0.05
67
487
320
2971
1.87
2.87
15.2
11.9
3.9
3.9
mmol/l
0.13
313
2882
319
2964
1.84
2.78
15.2
11.9
139.9
139.8
mmol/l
0.49
313
2881
14
54
2.66
2.73
2.7
3.1
—
—
—
0
0
65
443
1.57
2.62
2.5
1.9
2.4
2.4
mmol/l
0.15
57
380
312
2900
1.68
2.45
14.0
10.3
22.0
20.1
mg/l
0.46
250
2175
87
641
1.47
2.44
3.9
3.4
1.0
1.0
kg/l
1.00
14
86
10
34
3.00
2.43
2.0
1.5
—
—
—
0
0
226
1976
1.40
2.38
3.3
3.2
—
—
—
0
0
269
2438
1.44
2.21
15.6
12.6
13.6
13.5
%
0.48
261
2390
8
25
3.25
2.10
1.0
1.3
—
—
—
0
0
156
1306
1.35
2.04
5.9
3.5
12.3
11.5
umol/l
0.19
150
1222
80
600
1.43
2.03
1.6
1.5
—
—
—
0
0
5
11
4.59
1.94
1.4
1.7
3.1
2.9
mg/l
—
5
11
133
1094
1.35
1.93
1.8
1.9
97.0
99.0
pmol/l
0.16
68
535
55
390
1.49
1.86
2.0
2.3
0.7
1.0
e6/l
0.83
30
207
8
32
2.53
1.60
1.0
1.4
—
—
—
0
0
65
494
1.39
1.53
3.3
3.5
23.5
120.8
ng/l
2.43
45
354
5
15
3.37
1.53
1.4
2.3
—
—
—
0
0
35
239
1.52
1.44
2.0
1.7
—
—
—
0
0
77
608
1.34
1.43
1.5
1.4
—
—
—
0
0
26
166
1.61
1.42
1.6
1.8
—
—
—
0
0
23
355
0.62
1.39
3.6
4.4
30.6
32.8
%
0.36
14
232
35
241
1.50
1.39
8.4
7.2
14.0
11.8
kpa
1.55
35
234
35
241
1.50
1.39
8.4
7.3
5.2
5.2
kpa
0.08
35
232
6
24
2.53
1.31
1.3
1.3
—
—
—
0
0
41
297
1.43
1.28
2.3
2.1
22.2
6.2
umol/l
0.84
35
256
20
123
1.66
1.27
12.6
8.4
24.5
25.0
mmol/l
0.37
20
123
22
139
1.62
1.26
1.5
1.4
—
—
—
0
0
82
667
1.30
1.24
2.1
2.1
346.1
5957.1
umol/l
2.65
68
591
48
361
1.38
1.22
1.9
2.5
3.4
3.0
e6/l
0.13
22
177
13
71
1.86
1.21
1.1
1.2
—
—
—
0
0
252
2344
1.27
1.19
4.4
4.0
14.7
14.6
pmol/l
0.28
239
2156
13
72
1.84
1.16
1.5
1.4
—
—
—
0
0
83
684
1.28
1.14
2.8
2.8
905.1
1072.3
ng/l
0.27
69
567
11
58
1.93
1.13
1.3
1.2
—
—
—
0
0
76
620
1.29
1.13
1.9
1.7
0.8
0.9
mg/l
0.40
66
476
40
299
1.38
1.07
1.9
2.3
20.8
24.1
%
1.08
34
258
44
335
1.36
1.05
5.7
5.3
—
—
—
0
0
290
2760
1.29
1.03
5.2
4.7
1.7
2.3
mu/l
0.66
275
2538
33
240
1.41
1.03
5.5
6.1
105.4
104.6
mmol/l
0.47
33
234
70
574
1.27
1.00
1.3
1.3
12.5
40.9
iu/ml
5.34
25
192
99
850
1.23
0.95
2.4
2.1
55.1
57.0
u/l
0.23
94
794
6
28
2.16
0.92
1.3
1.4
—
—
—
0
0
32
237
1.39
0.92
2.0
1.7
—
—
—
0
0
8
44
1.84
0.86
1.0
1.1
—
—
—
0
0
284
2713
1.25
0.86
15.3
11.4
39.1
40.2
%
1.24
210
2041
44
348
1.30
0.84
2.2
1.7
—
—
—
0
0
6
33
1.83
0.79
1.3
1.3
—
—
—
0
0
32
245
1.34
0.77
2.3
2.4
21.3
17.7
au/ml
—
5
8
65
547
1.23
0.76
1.8
1.6
450.4
16009215.9
pmol/l
0.50
58
456
26
194
1.37
0.73
1.2
1.2
239.6
287.0
u/ml
0.12
26
180
320
3113
1.32
0.73
10.0
8.3
25.3
25.1
u/l
0.11
312
2998
9
56
1.62
0.73
1.2
1.5
—
—
—
0
0
5
26
1.94
0.71
1.0
1.2
—
—
—
0
0
66
562
1.21
0.69
1.3
1.3
11.9
11.1
u/ml
0.02
28
217
73
630
1.20
0.67
1.4
1.5
22.0
20.9
nmol/l
0.30
66
547
7
44
1.60
0.65
2.0
1.5
—
—
—
0
0
7
44
1.60
0.65
1.0
1.2
—
—
—
0
0
13
87
1.51
0.64
1.2
1.4
—
—
—
0
0
13
87
1.51
0.64
1.2
1.4
—
—
—
0
0
13
87
1.51
0.64
1.2
1.4
—
—
—
0
0
13
87
1.51
0.64
1.2
1.4
—
—
—
0
0
111
1002
1.16
0.60
3.4
3.2
22.6
76.4
ng/l
0.80
60
645
17
123
1.40
0.59
9.5
9.2
1.2
1.5
%
0.76
17
123
16
115
1.41
0.57
1.7
2.1
12.2
13.5
nmol/l
0.28
16
103
24
186
1.31
0.56
2.0
1.9
0.2
0.2
g/l
0.15
24
169
52
444
1.20
0.55
1.8
1.6
1161.4
1181.2
nmol/l
0.05
41
331
6
97
0.61
0.53
5.2
1.6
—
193.3
—
0
9
46
390
1.21
0.52
2.0
2.0
—
—
—
0
0
7
48
1.47
0.47
2.0
1.5
—
—
—
0
0
281
2728
1.15
0.46
11.7
9.0
84.7
83.8
ml/min/173m2
0.29
230
2166
26
211
1.25
0.45
2.0
1.9
—
—
—
0
0
16
122
1.33
0.43
10.0
9.2
0.9
0.7
%
1.07
16
122
14
105
1.35
0.41
2.6
2.4
3678.2
3381.4
u/l
—
6
46
5
37
1.36
0.37
1.4
1.3
—
—
—
0
0
5
37
1.36
0.37
1.4
1.3
—
—
—
0
0
23
277
0.82
0.37
2.7
2.4
0.5
0.7
ug/l
1.94
14
175
26
217
1.21
0.36
2.0
1.8
75.0
72.2
ml/min/173m2
—
10
93
6
41
1.47
0.36
1.0
1.0
—
—
—
0
0
15
117
1.29
0.36
1.6
1.3
248.5
283.9
miu/ml
—
8
60
205
1973
1.09
0.33
2.9
2.8
38.6
41.3
u/l
0.28
193
1848
40
352
1.15
0.32
1.8
1.9
—
—
—
0
0
27
315
0.85
0.32
1.6
1.6
—
—
—
0
0
13
101
1.30
0.32
1.2
1.5
—
—
—
0
0
44
391
1.14
0.32
4.2
3.4
22.9
24.6
%
0.30
22
163
10
76
1.33
0.28
1.9
1.8
0.2
1.3
ug/l
—
10
71
71
656
1.10
0.28
2.6
2.0
2.6
2.9
mg/l
0.89
65
553
9
116
0.77
0.28
1.8
1.7
—
—
—
0
0
8
66
1.22
0.27
1.3
1.3
—
—
—
0
0
5
38
1.32
0.23
1.0
1.2
—
—
—
0
0
16
134
1.20
0.23
1.0
1.4
—
—
—
0
0
5
39
1.29
0.23
1.0
1.0
—
—
—
0
0
7
92
0.76
0.22
2.4
1.9
—
—
—
0
0
19
163
1.18
0.22
1.0
1.0
—
—
—
0
0
126
1207
1.07
0.21
2.2
2.2
79.9
78.2
nmol/l
0.28
115
1073
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
0
13
0.00
0.21
0.0
2.2
—
—
—
0
0
19
166
1.15
0.18
1.5
1.5
—
—
—
0
0
7
63
1.11
0.17
3.6
2.7
25.0
24.9
mmol/l
—
7
55
20
225
0.88
0.16
5.0
2.8
—
—
—
0
0
11
92
1.20
0.16
1.1
1.3
—
—
—
0
0
75
714
1.06
0.15
1.3
1.3
0.9
2.0
u/ml
0.83
19
199
23
255
0.90
0.15
1.2
1.2
102.2
128.5
iu/ml
—
6
115
7
90
0.77
0.14
2.3
1.8
—
—
—
0
0
10
85
1.18
0.12
1.8
1.6
—
—
—
0
0
19
174
1.10
0.09
1.3
1.3
—
—
—
0
0
5
48
1.04
0.09
1.0
1.3
—
—
—
0
0
14
126
1.12
0.09
1.9
1.9
—
—
—
0
0
16
146
1.10
0.08
1.9
1.5
—
—
—
0
0
7
65
1.08
0.08
1.9
1.7
—
—
—
0
0
297
2950
1.04
0.08
4.3
4.3
4.8
4.8
mmol/l
0.03
275
2756
8
75
1.07
0.07
1.1
1.3
132.8
167.9
e6/l
—
8
61
9
101
0.89
0.06
1.6
3.6
0.9
1.2
%
—
9
101
284
2823
1.03
0.05
3.9
3.8
1.3
1.3
mmol/l
0.05
266
2617
135
1332
1.02
0.05
3.1
2.7
73.0
90.8
ug/l
1.51
126
1236
21
199
1.06
0.04
2.9
4.0
1.0
2.3
mmol/l
1.43
15
157
292
2933
0.97
0.04
4.2
4.3
1.5
1.5
mmol/l
0.79
270
2741
10
92
1.09
0.03
1.1
1.1
—
—
—
0
0
10
92
1.09
0.03
1.0
1.1
—
—
—
0
0
270
2689
1.02
0.02
5.4
5.3
39.0
39.2
mmol/mol
0.15
254
2529
300
2990
1.02
0.02
4.8
4.8
2.9
2.9
mmol/l
0.37
276
2786
10
106
0.94
0.01
1.4
1.6
—
—
—
0
0
288
2879
1.00
0.00
4.6
4.2
5.8
5.8
mmol/l
0.34
263
2653
11
107
1.03
0.00
1.4
2.0
—
—
—
0
0
12
123
0.97
0.00
1.5
2.2
0.4
0.2
e6/l
0.43
12
117
79
786
1.01
0.00
1.6
1.6
1.6
1.4
mmol/l
0.65
69
684
7
75
0.93
0.00
1.7
1.5
—
—
—
0
0
5
52
0.96
0.00
1.6
1.6
—
—
—
0
0
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
8.2
—
0
9
15
150
1.00
0.00
4.3
4.7
1.9
1.8
mmol/l
—
8
109
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
107.7
—
0
7
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
7
77
0.91
0.00
1.6
1.3
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
13
130
1.00
0.00
1.7
1.4
—
—
—
0
0
0
9
0.00
0.00
0.0
2.4
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
2.4
—
—
—
0
0
6
59
1.02
0.00
1.5
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
0.8
—
0
5
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_BONE_SKULL_FACE_EXALLC – Benign neoplasm: Bones of skull and face
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).